HomeCompareCCORF vs MRK

CCORF vs MRK: Dividend Comparison 2026

CCORF yields 2.98% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CCORF wins by $4.69M in total portfolio value
10 years
CCORF
CCORF
● Live price
2.98%
Share price
$8.28
Annual div
$0.25
5Y div CAGR
73.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.74M
Annual income
$3,762,451.42
Full CCORF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CCORF vs MRK

📍 CCORF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCCORFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CCORF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CCORF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CCORF
Annual income on $10K today (after 15% tax)
$253.55/yr
After 10yr DRIP, annual income (after tax)
$3,198,083.71/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CCORF beats the other by $3,189,755.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CCORF + MRK for your $10,000?

CCORF: 50%MRK: 50%
100% MRK50/50100% CCORF
Portfolio after 10yr
$2.40M
Annual income
$1,886,124.78/yr
Blended yield
78.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CCORF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.2
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CCORF buys
0
MRK buys
0
No recent congressional trades found for CCORF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCCORFMRK
Forward yield2.98%2.76%
Annual dividend / share$0.25$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR73.9%32.7%
Portfolio after 10y$4.74M$56.8K
Annual income after 10y$3,762,451.42$9,798.13
Total dividends collected$4.63M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CCORF vs MRK ($10,000, DRIP)

YearCCORF PortfolioCCORF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,219$518.74$11,206$366.19+$13.00CCORF
2$12,950$945.82$12,650$502.35+$300.00CCORF
3$15,631$1,774.38$14,407$694.19+$1.2KCCORF
4$20,206$3,480.77$16,585$967.82+$3.6KCCORF
5$28,933$7,312.82$19,342$1,363.89+$9.6KCCORF
6$47,977$17,018.42$22,913$1,947.19+$25.1KCCORF
7$97,199$45,864.10$27,662$2,823.89+$69.5KCCORF
8$255,018$151,015.43$34,159$4,173.35+$220.9KCCORF
9$916,811$643,941.78$43,337$6,308.80+$873.5KCCORF
10$4,743,440$3,762,451.42$56,776$9,798.13+$4.69MCCORF

CCORF vs MRK: Complete Analysis 2026

CCORFStock

Canaccord Genuity Group Inc., a full-service financial services company, provides investment products, and investment banking and brokerage services to institutional, corporate, and private clients. It operates in two segments, Canaccord Genuity Capital Markets and Canaccord Genuity Wealth Management. The Canaccord Genuity Capital Markets segment offers investment banking, advisory, research, merger and acquisition, sales, and trading services. The Canaccord Genuity Wealth Management segment provides wealth management solutions, and brokerage and financial planning services to individual investors, private clients, charities, and intermediaries. The company operates in North America, the United Kingdom, Europe, Asia, Australia, and the Middle East. Canaccord Genuity Group Inc. was founded in 1950 and is headquartered in Vancouver, Canada.

Full CCORF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CCORF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CCORF vs SCHDCCORF vs JEPICCORF vs OCCORF vs KOCCORF vs MAINCCORF vs JNJCCORF vs ABBVCCORF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.